The Vioxx debacle revisited.
Mohapatra
Prasanta Raghab
PR
Janmeja
Ashok Kumar
AK
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D017277:Drug Approval; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D013450:Sulfones / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib